Immunotherapy for Multiple Myeloma: A New Generation of Chimeric Antigen Receptors and Immune Checkpoint Blockade

Basic Information

Funding Cycle : 2021-2022
Name : Carlos Fernández de Larrea
Type of Award : Translational Research Award
Home Institution : Fundació Clínic per a la Recerca Biomèdica, Spain
Host Institution : N/A


ipsum lorem

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Stay updated on our Events